Alamo Group Inc. announced a quarterly dividend of $0.34 per share, payable on October 28, 2026, to shareholders of record as of October 15, 2026. The company, a leader in industrial and vegetation management equipment, serves various markets including infrastructure, agriculture, and public works. This dividend reflects Alamo Group's ongoing commitment to returning value to shareholders amid its global operations and diverse product offerings. Investors can expect this payment as part of the company's regular dividend schedule.
Alamo Group Inc.'s dividend announcement is presented here with Industrials sector data from Pluang. For readers following Industrials, 69 of 93 priced US stocks rose and 24 fell today. Notable movers include Badger Meter Inc at USD 128.52 (+4.03%), Star Bulk Carriers Corp at USD 30.54 (+4.02%) with 100% buy order activity, and C.H. Robinson Worldwide, Inc. at USD 153.80 (+3.95%) with 100% buy order activity. This data is as of Oct 02, 2026 02:51 WIB.
Wells Fargo initiated coverage on BlackRock with an 'Overweight' rating, highlighting it as a good entry point for investors. Analysts expect BlackRock's Q3 earnings per share to rise to $14.25 from $11.55 a year ago, with revenue projected at $7.56 ...
Nike reported earnings per share of $0.48, beating estimates, but revenue fell short at $11.21 billion due to weak demand in Greater China and rising competition. The company issued a cautious fiscal 2027 outlook with EPS forecast between $1.15 and $...
NETSOL Technologies reported a record $20.7 million revenue in fiscal 2026 Q4, with net income rising 45.9% to $3.8 million. The company improved its gross margin to 63.6% and operating margin to 21.6%, reflecting enhanced profitability. For fiscal 2...
On October 1, 2026, Nexalin Technology surged 76.4% after securing a 10-year exclusive deal for its medical device in South America. Armada Acquisition Corp. II jumped 42.9% following shareholder approval of its merger with Evernorth, expected to clo...
Jefferies analyst Roger Song set a $150 price target for Nektar Therapeutics, suggesting a 219% upside from its $46.99 trading price. This comes after Nektar presented positive six-month Phase IIb trial results for its alopecia drug REZPEG, which als...
